Skip to main content
PLUR
NASDAQ Life Sciences

Pluri's Ever After Foods Acquires Fishway, Adds $2M SAFE Investment

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$1.6
Mkt Cap
$17.263M
52W Low
$1.45
52W High
$5.68
52W Position info
10% above low
Off High info
72% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

PLUR is trading near its 52-week low of $1.45 (10% above the low) on elevated volume (1.8× avg).

Summary

Ever After Foods, Pluri's 69%-owned subsidiary, agreed to acquire Fishway BV and secured a $2.0 million SAFE investment. Pluri's ownership in EAF will fall to about 58% after closing.


Key Events · M&A and Partnerships · PLUR

  • EAF Acquires Fishway BV

    Ever After Foods, Pluri's indirect majority-owned subsidiary, entered into a share purchase agreement to acquire all outstanding share capital of Fishway BV, a Belgian company with cell lines and culture media for cultivated seafood.

  • $2.0M SAFE Investment

    In connection with the transaction, certain Fishway sellers agreed to invest $2.0 million in EAF through a simple agreement for future equity (SAFE).

  • Pluri Ownership Dilution

    Pluri's indirect ownership in EAF is expected to decrease from approximately 69% to approximately 58% following completion of the transaction.

  • Closing Expected Within 30 Days

    The transaction is expected to close within 30 days of the share purchase agreement dated August 12, 2026, subject to customary closing conditions.


Analysis · PLUR · Life Sciences

Pluri's majority-owned subsidiary Ever After Foods (EAF) is acquiring Fishway BV, a Belgian company with cell lines and culture media for cultivated seafood. The deal includes a $2.0 million SAFE investment from Fishway sellers. Pluri's indirect ownership in EAF will drop from about 69% to 58%, diluting Pluri's stake but bringing in capital and European presence. This comes as Pluri faces a Nasdaq delisting notice and acute liquidity concerns, making the $2M investment and strategic expansion notable.

At the time of this filing, PLUR was trading at $1.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $17.3M. The 52-week trading range was $1.45 to $5.68. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PLUR - Latest Insights

PLUR
Aug 17, 2026, 8:31 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $1.62
Real-time Price: $1.60 info
Change: -$0.020 (-1%) info
Market Cap: $17.263M info
PLUR
Jul 28, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.74
Real-time Price: $1.60 info
Change: -$0.140 (-8%) info
Market Cap: $17.263M info
PLUR
Jul 14, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.68
Real-time Price: $1.60 info
Change: -$0.080 (-5%) info
Market Cap: $17.263M info
PLUR
Jul 13, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.63
Real-time Price: $1.60 info
Change: -$0.030 (-2%) info
Market Cap: $17.263M info
PLUR
Jul 01, 2026, 4:01 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $2.09
Real-time Price: $1.60 info
Change: -$0.490 (-23%) info
Market Cap: $17.263M info